Related by context. All words. (Click for frequent words.) 72 lintuzumab SGN 71 MAGE A3 ASCI 70 Panzem R 70 MKC# MT 69 PDE4 inhibitor 68 delta opioid receptor 68 LymphoStat B belimumab 68 urocortin 2 68 non nucleoside inhibitor 68 phase III isavuconazole 68 XOMA 3AB 68 adalimumab Humira 68 intranasal formulation 68 liposomal formulation 68 RELOVAIR ™ 67 midstage clinical 67 IMiDs ® 67 albiglutide 67 Aflibercept 67 AAG geldanamycin analog 67 candidate XP# 67 antibody MAb 67 Liprotamase 67 humanized therapeutic 67 GW# [003] 67 Saxagliptin 67 TBC# 67 GVAX ® 67 mertansine 67 DEB# 67 CIMZIA TM 67 RhuDex ® 66 Bezielle 66 XL# anticancer compounds 66 MAXY alpha 66 XL# XL# XL# XL# 66 mitoxantrone plus 66 Panzem R NCD 66 IMiDs R 66 oral prodrug 66 Zemplar Capsules 66 PORxin TM platforms 66 SinuNase ™ 66 R#/MEM # 66 rxRNA 66 hyaluronidase enzyme 66 novel histone deacetylase 66 PSMA ADC 66 paclitaxel Taxol ® 66 CEQ# 66 RANK Ligand inhibitor 66 immune modulating 66 Proellex TM 66 midstage trials 66 mGluR5 NAM 66 CYT# potent vascular disrupting 66 Tarceva TM 66 Matrix Phase 2b 66 sitaxsentan 66 Telik logo TELINTRA 66 novel VDA molecule 66 oral talactoferrin 66 SinuNase TM 66 metaglidasen 66 small molecule Hedgehog 66 HCD# [002] 66 human IgG1 monoclonal 66 orally administered inhibitor 66 relapsed MM 66 MEK inhibitor 66 demonstrated antitumor activity 66 CIMZIA TM certolizumab pegol 66 forodesine 66 azilsartan medoxomil 66 oxymorphone ER 65 volociximab 65 PEGylated Fab fragment 65 PDE# inhibitors 65 ALN HPN 65 Aryplase 65 PF # [002] 65 anti CD3 monoclonal 65 including eniluracil ADH 65 R sorafenib tablets 65 treat chronic sinusitis 65 humanised monoclonal antibody 65 Omacetaxine 65 clinical trials SGN 65 chimeric monoclonal antibody 65 HCV RNA polymerase 65 hA# 65 investigational monoclonal antibody 65 ALN VSP Phase 65 Hsp# Inhibitor 65 acetonide FA 65 nalbuphine ER 65 targeted radiotherapeutic 65 evaluating mipomersen 65 baminercept 65 Oral NKTR 65 Parathyroid Hormone 65 P#X# antagonist 65 Archexin 65 Virulizin ® 65 GSK# [001] 65 investigational humanized monoclonal antibody 65 Pathway Inhibitor 65 Phase IIb clinical trials 65 HQK 65 HGS ETR1 mapatumumab 65 MOVIPREP R 65 acyclovir Lauriad R 65 administered subcutaneously 65 docetaxel Taxotere ® 65 2 methoxyestradiol 65 INCB# [001] 65 PEGylated anti 65 YONDELIS 65 MKC# 65 oral picoplatin 65 Crofelemer budesonide foam 65 Zorbtive TM 65 NOX E# 65 XP# XP# 65 HCV polymerase 65 ZOLINZA 65 Elotuzumab 65 CD# CEA 65 rhIGF-I/rhIGFBP-3 65 Prodarsan R 65 Allovectin 7 ® 65 MKC# MKC# PP 65 Solazed 65 Febuxostat 65 compound INCB# 65 selective phosphodiesterase 65 topical gel formulation 65 PEG SN# 65 RAPTIVA 65 beta 1a 65 telomerase therapeutic 64 5 HT3 antagonist 64 THR beta agonist 64 EXPAREL TM 64 maximally tolerated dose 64 LymphoStat B TM 64 combines bupropion 64 Phase 2b Clinical Trial 64 Pruvel 64 refractory gout 64 INSPIRE Trial Phase III 64 Letairis ambrisentan 64 Rigel R# 64 QNEXA ® 64 Aptivus ® 64 Maribavir 64 insulin glulisine 64 Canvaxin TM 64 refractory chronic lymphocytic 64 non nucleoside HCV 64 calcineurin inhibitor 64 R lenalidomide 64 5 HT2A inverse 64 GLPG# 64 R Saizen R 64 TRX1 64 IAP inhibitor 64 Sudhir Agrawal D.Phil 64 ularitide 64 proteasome inhibitor 64 muscarinic receptor agonist 64 evaluating tivozanib 64 octreotide acetate 64 PRT# 64 Teriflunomide 64 NeuroSTAT ® 64 teriflunomide 64 PI3K/Akt pathway inhibitor 64 Adenoscan R 64 Copegus ® 64 hyperphenylalaninemia HPA due 64 peptidic compound 64 6R BH4 64 Fibrillex TM 64 UVIDEM 64 huC# DM4 64 lomitapide 64 sodium thiosulfate STS 64 GVAX R 64 ADL# novel 64 TNF Tumor Necrosis Factor 64 adecatumumab MT# 64 pioglitazone HCl 64 KRN# 64 Muraglitazar 64 SAR# [004] 64 Ocrelizumab 64 receptor inhibiting monoclonal 64 plus prednisone prednisolone 64 Excellarate TM 64 IMiDs ® compound 64 Phenoptin 64 orally dosed 64 Budesonide foam crofelemer 64 Cloretazine ® 64 trastuzumab Herceptin R 64 pegylated alpha interferon 64 ATL# [002] 64 p# MAP kinase inhibitor 64 Genentech Rituxan 64 thalidomide Thalomid 64 protein kinase inhibitor 64 SAR# [002] 64 cathepsin K inhibitor 64 adenosine injection 64 docetaxel Taxotere R 64 treatment naive genotype 64 Submits Response 64 HCV protease inhibitors 64 Panzem ® 64 phase IIb trial 64 certolizumab 64 CIMZIA ™ 64 novel oral anticoagulant 64 PHX# 64 TransVax 64 non constipating irritable 64 lenalidomide Revlimid R 64 investigational oral hepatitis C 64 systemic RNAi therapeutic 64 Androxal TM 64 RhuDex R 64 Aztreonam lysine 64 Dapagliflozin 64 oral nucleoside analogue 64 kidney urologic 64 either acutely decompensated 64 Ophena TM 64 pan histone deacetylase 64 motesanib 64 MT#/MEDI-# 64 pralatrexate injection folate analogue 64 vinca alkaloid 64 etanercept Enbrel 64 sorafenib tablets 63 pegylated interferon alpha 63 MEK Inhibitor 63 Xelox 63 sapacitabine CYC# 63 adenosine A2A 63 AERx ® 63 Personalized Immunotherapy 63 Orally administered 63 Cimzia TM 63 fusion enhancers 63 trastuzumab emtansine T DM1 63 selective A2A adenosine receptor 63 elotuzumab 63 LAB CGRP 63 reduce serum phosphate 63 novel chimeric natriuretic 63 aplindore 63 includes TOLAMBA TM 63 eosinophilic asthma 63 Albuferon albinterferon alfa 2b 63 HGS ETR2 63 ENMD # 63 GLP toxicology studies 63 CINTREDEKIN BESUDOTOX 63 highly selective inhibitor 63 Intravitreal injections 63 topically applied SEPA 63 recombinant PSMA vaccine 63 interferon alfa 2b 63 estramustine 63 lumiliximab 63 PEGylated interferon 63 clinical trials dacetuzumab SGN 63 oral dihydropyrimidine dehydrogenase DPD 63 Plicera 63 Diamyd ® 63 BRILINTA 63 Triapine R 63 HepeX B 63 prescribed proton pump 63 TELINTRA R 63 latrepirdine 63 TPI ASM8 63 Begins Dosing 63 dasatinib Sprycel ® 63 ATL# [001] 63 PREOS R 63 phase IIb study 63 peptibody 63 mTOR mammalian target 63 tubulin inhibitor 63 CCR5 mAb 63 Vidaza azacitidine 63 protein tyrosine phosphatase 1B 63 alkylating agent 63 delivers fluocinolone acetonide FA 63 Gamunex C 63 cMET 63 prednisone prednisolone plus 63 Ostarine ™ 63 sodium glucose cotransporter 63 RezularTM 63 Dacogen decitabine 63 ancrod 63 vapreotide acetate 63 reversible inhibitor 63 memantine HCl 63 Presents Preclinical 63 selective modulator 63 Initiates Phase II 63 PEG PAL 63 sterile lidocaine patch 63 using VIAdel TM 63 Fx #A 63 CCX# 63 oral ridaforolimus 63 HCV NS5B polymerase 63 Nanobody R 63 Pegloticase 63 HoFH 63 Daclizumab 63 INxin TM 63 Thalomid ® 63 COLAZAL R 63 Initiate Clinical Trial 63 8mg/kg 63 dosing cohort 63 guanfacine extended release 63 erlotinib Tarceva ® 63 GRNVAC1 63 selective androgen receptor modulator 63 Nanobody 63 ® lenalidomide 63 G#DT 63 Sapacitabine 63 BENLYSTA TM 63 TLR9 agonist 63 mitogen activated ERK kinase 63 TransVax TM 63 MTP inhibitor 63 NS5b 63 JAK2 inhibitor 63 Kamada AAT 63 virus HCV protease inhibitor 63 TKM ApoB 63 Pruvel TM 63 Mipomersen 63 achieved ACR# 63 MCSP respectively 63 RTP #i 63 Initiates Clinical 63 Xeloda ® 63 treatment naïve genotype 63 BCR ABL inhibitor 63 BENICAR HCT 63 non splenectomized 63 Aurexis 63 Cloretazine 63 Elvitegravir 63 gemcitabine cisplatin 63 alemtuzumab Campath 63 anti amnesic 63 SPRYCEL ® 63 IgG1 monoclonal antibody 63 PSN# [002] 63 Achieves Primary Endpoint 63 Traficet EN 63 TELINTRA 63 FOLOTYN ® 63 efavirenz emtricitabine 63 neratinib 63 desvenlafaxine succinate 63 Pradefovir 63 agonistic human 63 systemically administered 63 inhaled formulation 63 AFREZZA TM 63 mGluR2 positive 63 novel synthetic PEGylated 63 investigational hepatitis B 63 opioid induced bowel dysfunction 63 small molecule thrombopoietin 63 pathophysiological effects 63 Proquin XR 63 Peginterferon alfa 2b 63 Vitaxin 63 dextromethorphan quinidine 63 Q#IR 63 PORxin TM 63 Pegylated interferon 62 Aloxi injection 62 integrin inhibitor 62 topically administered 62 VEGFR2 inhibitor 62 Allovectin 7 62 Bosutinib 62 alvespimycin 62 Solazed TM 62 lead Aganocide compound 62 selective agonist 62 low dose cytarabine 62 HepeX B TM 62 vidofludimus 62 EndoTAG 62 ascending dose 62 galiximab 62 Temsirolimus 62 oral salmon calcitonin 62 preclinical efficacy 62 CYP#A# CYP#D# 62 OvaRex ® MAb 62 rilonacept 62 antiretroviral naïve 62 Alocrest 62 investigational pharmacologically unique 62 Alfacell proprietary ribonuclease 62 mda 7 62 prasterone 62 Investigational Oral 62 fosbretabulin 62 Kinoid 62 Genz # 62 selective S#P# receptor agonist 62 Xcytrin R 62 GSK# [002] 62 abacavir lamivudine 62 Bystolic nebivolol 62 HuCAL antibodies 62 Phase #b/#a trial 62 Veronate R 62 oncolytic virus therapies 62 Parathyroid hormone 62 PrevOnco 62 ViaDerm hPTH #-# 62 unresectable HCC 62 selective estrogen receptor modulator 62 antisense inhibitors 62 MORAb 62 Submits Biologics License Application 62 TRIOLEX HE# APOPTONE HE# 62 humanized interleukin 6 62 generation purine nucleoside 62 sulfonylurea metformin 62 receptor inhibitor 62 XL# XL# 62 Locteron ® 62 KSP inhibitor 62 ALN TTR 62 Seliciclib 62 Initiates Clinical Trial 62 pharmacokinetic PK study 62 ICA # 62 GRN# 62 IMiDs 62 RAPTIVA r 62 ALN PCS 62 Tykerb lapatinib 62 inhibitor PPI 62 apoptosis inducer 62 CDP# 62 ara C 62 telaprevir VX 62 motesanib diphosphate 62 Survivin antagonist 62 Pharmacokinetics PK 62 Spiegelmer ® 62 torsemide ER 62 topoisomerase II inhibitor 62 nucleoside analog 62 Prodarsan ® 62 targeted antifolate 62 subcutaneously administered 62 zileuton 62 myelodysplastic myeloproliferative diseases 62 subcutaneous PRO 62 PRN FDA Approves 62 brivanib 62 Gemzar gemcitabine 62 ® bortezomib 62 INTEGRILIN R eptifibatide Injection 62 docetaxel Taxotere 62 microtubule inhibitor 62 approved incretin mimetic 62 CR# vcMMAE 62 Meets Primary Endpoint 62 CYT# QbG# 62 cisplatin gemcitabine 62 E1 INT TM 62 Silodosin 62 Proleukin 62 Darinaparsin 62 CRLX# 62 Hedgehog Pathway Inhibitor 62 Anturol TM 62 CTAP# Capsules 62 Exherin TM 62 huN# DM1 62 ascending doses 62 cyclophilin inhibitors 62 KNS # 62 Pimavanserin 62 oral proteasome inhibitor 62 metformin sulfonylurea 62 nucleotide analog 62 vinorelbine tartrate 62 tramiprosate Alzhemed TM 62 TG# [003] 62 Pafuramidine 62 isoform selective 62 taxane resistant 62 MSCRAMM ® 62 IL# PE#QQR 62 headache nasopharyngitis 62 GLP1 agonist 62 BrachySil TM 62 Phase 1b clinical trials 62 Reports Preclinical Data 62 alefacept 62 Phase #b/#a clinical 62 Phase IIb Clinical Trial 62 monoclonal antibody conjugated 62 intravenous acetaminophen 62 class mGluR5 inhibitor 62 Evoltra ® 62 TRAIL receptor antibodies 62 drug ISA# 62 ALGRX 62 midstage clinical trials 62 cysteamine bitartrate 62 inhaled AAT 62 catheter occlusion 62 adult chronic ITP 62 maximally tolerated lipid lowering 62 ACTEMRA TM 62 Dasatinib 62 Recombinant Human 62 Initiates Enrollment 62 OvaRex R 62 novel emulsion formulation 62 de novo kidney transplant 62 highly purified pasteurized 62 dacetuzumab SGN 62 factor TNF receptor 62 zoledronic acid Reclast 62 Genasense ® oblimersen 62 bone marrow reticulin deposition 62 Saforis 62 Glufosfamide 62 SPL# Gel vaginal microbicide 62 Urocortin 2 62 Zenvia ™ 62 Triapine 62 TLR7 agonist 62 RhuDex TM 62 nucleotide analogue 62 IMPDH inhibitor 62 methylnaltrexone bromide 62 Mg Usa 62 Files IND 62 registrational studies 62 Epothilones 62 cleavable linker 62 tolevamer 62 genotypic resistance 62 IMA# 62 TRPV1 agonist 62 R# #mg BID 62 trastuzumab DM1 T DM1 62 Kosan dependence 62 prokinetic agent 62 Belerofon 62 budesonide foam 62 PDX pralatrexate 62 oxaliplatin Eloxatin 62 Pertuzumab 62 thetreatment 62 OMNARIS HFA 62 topical antifungal 62 lexidronam injection 62 ADP receptor antagonist 62 oral beclomethasone dipropionate 62 Behcet uveitis 62 GERD migraine headaches 62 injectable investigational 62 QNEXA 62 torezolid phosphate 62 inhibit oxidative stress 62 reslizumab 62 Remicade infliximab 62 NV1FGF 62 Copegus R 62 taxane chemotherapy 62 diarrhea predominant irritable 62 Pazopanib 62 omalizumab Xolair 62 Vicinium TM 62 Cinquil 62 Inc. Nasdaq MITI 62 Cethrin R 62 Phase Ib IIa 62 Phase 2a clinical trials 62 GAMMAGARD 62 Elagolix 62 Onglyza saxagliptin 62 synthetic retinoid 62 tumor xenograft models 62 Specifid 62 successfully commercialize Iluvien 62 Aganocide ® 62 hPTH #-# 62 Zalypsis 62 development peramivir neuraminidase 62 DPP4 inhibitor 62 Completes Patient Enrollment 62 Actilon 61 mg TID 61 Cariprazine 61 pharmacologically active isomer 61 Pharmos pipeline 61 Onconase 61 nasal calcitonin product 61 polymerase inhibitor 61 Voreloxin 61 Cloretazine R VNP#M 61 oxypurinol 61 FUSILEV enhances 61 containing abacavir 61 Vertex hepatitis C 61 TKB# 61 Perforomist TM formoterol fumarate 61 darunavir r 61 hypoxia selective 61 polysaccharide polymer 61 oral rivaroxaban 61 Zemiva TM 61 orally bioavailable 61 VNP#M 61 Ganciclovir 61 ChronVac C R 61 Panzem 61 Panzem NCD 61 BENLYSTA ® 61 Forodesine HCl 61 PNP inhibitor 61 Phase Ib study 61 Tezampanel 61 Atrasentan 61 pharmacogenomic translational research 61 LEP ETU 61 personalized cellular immunotherapy 61 immune modulatory 61 evaluating Xcytrin 61 dutogliptin 61 recombinant biopharmaceutical 61 infliximab monotherapy 61 CB2 selective receptor agonist 61 GEM OS2 61 Albugon 61 Tasimelteon 61 CINQUIL 61 EDEMA3 61 vWF 61 Monoclonal antibody 61 oral immunomodulatory 61 Ribavirin causes 61 dimebon latrepirdine 61 brand ciclesonide HFA 61 weekly subcutaneous injections 61 FOR FURTHER INFORMATION ABOUT 61 thrombin inhibiting aptamer 61 small molecule glucokinase 61 A1PI 61 toenail onychomycosis 61 rusalatide acetate 61 M# rationally 61 Empatic ™ 61 AzaSite Plus 61 non nucleoside 61 filgrastim 61 solanezumab 61 Hepatitis C HCV 61 pamidronate 61 receptor tyrosine kinase inhibitor 61 familial hypercholesterolemia FH 61 inhalations twice 61 TLK# 61 Pegasys ® 61 ISIS # 61 aripiprazole Abilify 61 Phase 1a clinical 61 Varespladib 61 bevirimat Study 61 accumulate preferentially 61 BHT DNA 61 Immunotherapeutic 61 AEG# 61 Qutenza TM 61 Pivotal Phase III 61 include Phenoptin TM 61 RhuDex 61 rheumatoid arthritis psoriatic arthritis 61 Capesaris 61 SNT MC# 61 #D#C# 61 LAF# 61 ASG 5ME 61 lenalidomide dexamethasone 61 BYETTA exenatide injection 61 ® natalizumab 61 ChronVac C 61 product candidate Lpathomab 61 TÎ ² 4 61 interferon gamma 1b 61 proprietary intravenous formulation 61 intravenous iv 61 Increlex TM 61 histone deacetylase HDAC inhibitor 61 aerosolized AAT 61 Kahalalide F 61 Vascular Disrupting Agent 61 ocular formulation 61 TransVax ™ 61 phase Ib 61 Phase Ib II 61 colesevelam HCl 61 lucinactant 61 HCV polymerase inhibitors 61 clevidipine 61 Pharmacokinetic parameters 61 PPAR agonist 61 BEMA Granisetron 61 personalized dendritic cell 61 pain palliation 61 Glatiramer acetate 61 gastrin analogue TT 61 Aplidin 61 AVE# 61 Valopicitabine 61 siRNAs targeting 61 fostamatinib 61 anthracycline taxane 61 ritonavir boosted 61 μg dose 61 Anthim 61 HBeAg + 61 administered intranasally 61 rituximab Rituxan 61 preclinical pharmacokinetic 61 Xanafide 61 Sustiva efavirenz 61 PEG irinotecan 61 USL# 61 TKM PLK1 61 monoclonal antibody IgG1 Mab 61 Enzastaurin 61 diabetic neuropathic pain 61 ospemifene 61 BioNumerik 61 aflibercept VEGF Trap 61 OMNARIS Nasal Spray 61 HepDirect prodrug 61 HCV protease inhibitor 61 BUPHENYL R 61 NXL# 61 ATPace TM 61 hoFH 61 corticosteroid dexamethasone 61 sulfonylurea glimepiride 61 Vernakalant 61 GPR# agonist 61 Cancidas 61 Tesetaxel 61 mild vasodilator 61 Luteinizing Hormone Releasing Hormone 61 Iloperidone 61 Pyridorin TM 61 OMP #R# 61 adefovir dipivoxil 61 glucokinase activator 61 targeted nucleotide prodrug 61 M2 subunit 61 pramlintide metreleptin 61 Qnexa TM 61 basal bolus regimen 61 milatuzumab 61 Lisofylline LSF 61 Testosterone MDTS ® 61 Amigal TM 61 Toremifene 61 alfa 2a 61 injectable formulation 61 Hedgehog antagonist 61 sulfonylhydrazine class 61 piperacillin tazobactam 61 TRO# 61 Initiates Phase III 61 Atripla combines 61 histamine dihydrochloride 61 humanized monoclonal 61 Initiated Phase 61 Anidulafungin 61 R vitespen 61 CCR9 antagonist 61 Engerix B 61 Arimoclomol 61 developing Bicifadine serotonin 61 efaproxiral 61 selective antagonist 61 JZP 61 lesinurad 61 Amrubicin 61 novel topoisomerase 61 OMP #M# 61 pertuzumab 61 Granulocyte Colony Stimulating Factor 61 Sutent sunitinib 61 Ecallantide 61 investigational protease inhibitor 61 Copegus ribavirin 61 Aganocide 61 Nexavar sorafenib tablets 61 PEGylated 61 TRACON Pharmaceuticals 61 alpha folate receptor 61 non porcine pancreatic 61 REMINYL ® 61 HuMax EGFr 61 anti botulism antibody 61 taxane refractory 61 RGB # 61 Tanespimycin 61 mcg BID 61 Naive Patients 61 ART# 61 reformulates existing FDA 61 RSD# oral 61 Ovitrelle R Serostim 61 thymalfasin 61 Alferon N 61 ionotropic glutamate receptor antagonists 61 R abatacept 61 Oracea TM 61 ATRA IV 61 Anticalins R 61 Diamyd r 61 TNF alpha antagonist 61 Posiphen TM 61 Boniva ibandronate 61 RiVax 61 haematologic 61 Phase 2b clinical trials 61 Decitabine 61 inhaled liposomal ciprofloxacin 61 novel orally inhaled 61 ARIKACE ™ 61 Neupogen ® 61 pomalidomide 61 Platinol ® cisplatin 61 atacicept 61 Prosaptide 61 VitiGam TM 61 Syncria 61 primary hypercholesterolemia 61 UPLYSO 61 histone deacetylase HDAC 61 Mg Uk 61 GLIADEL R Wafer 61 tenofovir Viread 61 severe hypersensitivity reactions 61 Campath ® 61 humanized anti 61 small molecule tyrosine 61 fluocinolone acetonide 61 nitric oxide donating prostaglandin 61 Romiplostim 61 developing ACAPODENE 61 AQ4N 61 retinal vein occlusion induced 61 therapeutic monoclonal antibody 61 Submits NDA 61 Zybrestat 61 markets HP Acthar 61 hormone LHRH antagonist 61 INTEGRILIN ® 61 mg RDEA# 61 Entereg R 61 Successfully Completes Phase 61 progressive metastatic prostate 61 HuLuc# 61 evaluating picoplatin 61 Telintra 61 Cetrorelix 61 Genasense oblimersen sodium Injection 60 CHAMPION PCI 60 Cleviprex TM clevidipine 60 JAK#/JAK# inhibitor CYT# 60 RNA antagonist 60 PD LID 60 Protexia ® 60 Genasense R oblimersen 60 granisetron formulated 60 FOLFOX chemotherapy 60 briakinumab 60 hypoxia activated prodrug 60 serotonin norepinephrine reuptake inhibitor 60 leading oral taxane 60 selective orally bioavailable 60 HuMax TAC 60 Oral Calcitonin 60 Nipent R 60 AGHD 60 mg/m2 administered 60 Diabetic Macular Edema DME 60 potassium binder 60 topical ophthalmic 60 Interferon alfa 60 OMS# 60 HMG CoA reductase inhibitors 60 cosmetic cosmeceutical products 60 dose escalation phase 60 CTA# Injection 60 aurora kinase 60 null responder 60 Xoma Ltd 60 non peptidic protease 60 CIP TRAMADOL ER 60 MSCRAMM R 60 bortezomib Velcade 60 novel synthetic peptide 60 sargramostim 60 Ostabolin C TM 60 Neulasta R 60 idiopathic thrombocytopenic purpura ITP 60 LibiGel ® 60 ApoB SNALP 60 statin monotherapy 60 sulodexide 60 paclitaxel poliglumex 60 Vidofludimus 60 novel DACH platinum 60 trivalent influenza vaccine 60 Afatinib 60 alvimopan 60 Ataluren 60 indiplon capsules 60 Civacir 60 inhaled TPI ASM8 60 Troxatyl 60 CIMZIA r 60 next generation URAT1 60 IMC #B 60 arsenic trioxide injection 60 Potelligent Technology 60 Somatuline R Autogel R 60 IRX 2 60 long acting muscarinic 60 Amgen Neulasta ® 60 NASDAQ REGN 60 Ixempra 60 somatostatin analog 60 trial evaluating PRX# 60 potent suppressor 60 Hedgehog inhibitor 60 ASONEP ™ 60 MAP# 60 Nexavar sorafenib 60 SUVN 60 EOquin TM phase 60 Luveris R Ovidrel R 60 receptor blocker 60 Phase III Pivotal 60 dexamethasone Decadron 60 IV Busulfex 60 Protexia R 60 ® pioglitazone HCl 60 TNF alpha selectively neutralizing 60 RNA antagonists 60 anti PlGF 60 CCR5 receptor antagonist 60 Zavesca R 60 Valproic acid 60 CORT # 60 candidate deforolimus 60 Arcalyst 60 mecarbil 60 recurrent glioblastoma multiforme 60 developing Zerenex ferric 60 pan HDAC inhibitor 60 oral taxane 60 pharmacodynamic PD 60 Preclinical studies suggest 60 Benazepril 60 teplizumab 60 SILENOR TM doxepin HCl